(ACT) AlzChem - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A2YNT30

ACT: Chemicals, Supplements, Pharmaceuticals, Coatings, Ceramics, Gases

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany. Web URL: https://www.alzchem.com

Additional Sources for ACT Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ACT Stock Overview

Market Cap in USD 628m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

ACT Stock Ratings

Growth 5y 83.5%
Fundamental 76.4%
Dividend 67.2%
Rel. Strength Industry 1337
Analysts -
Fair Price Momentum 69.12 EUR
Fair Price DCF 279.85 EUR

ACT Dividends

Dividend Yield 12m 1.98%
Yield on Cost 5y 6.98%
Annual Growth 5y 9.86%
Payout Consistency 94.6%

ACT Growth Ratios

Growth Correlation 3m 66.9%
Growth Correlation 12m 91.3%
Growth Correlation 5y 57.2%
CAGR 5y 28.40%
CAGR/Mean DD 5y 2.21
Sharpe Ratio 12m 2.28
Alpha 131.89
Beta 0.45
Volatility 35.97%
Current Volume 14.6k
Average Volume 20d 12.5k
What is the price of ACT stocks?
As of January 22, 2025, the stock is trading at EUR 60.60 with a total of 14,584 shares traded.
Over the past week, the price has changed by -5.61%, over one month by +4.48%, over three months by +2.36% and over the past year by +150.13%.
Is AlzChem a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, AlzChem (XETRA:ACT) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 76.39 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACT as of January 2025 is 69.12. This means that ACT is currently undervalued and has a potential upside of +14.06% (Margin of Safety).
Is ACT a buy, sell or hold?
AlzChem has no consensus analysts rating.
What are the forecast for ACT stock price target?
According to ValueRays Forecast Model, ACT AlzChem will be worth about 75.2 in January 2026. The stock is currently trading at 60.60. This means that the stock has a potential upside of +24.16%.
Issuer Forecast Upside
Wallstreet Target Price 74.2 22.4%
Analysts Target Price - -
ValueRay Target Price 75.2 24.2%